ALX Oncology Holdings Inc.

Rachunek Zysków i Strat





index 0 1 2 3 4 5 6
Rok finansowy 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 5 1 0 0 0 0
Przychód Δ r/r 0.0% 132.0% -75.4% -100.0% 0.0% 0.0% 0.0%
Marża brutto 9.0% 9.1% 9.1% -inf% -inf% -inf% 0.0%
EBIT (mln) -14 -19 -44 -84 -127 -170 -142
EBIT Δ r/r 0.0% 40.2% 127.6% 91.4% 52.5% 33.6% -16.3%
EBIT (%) -662.0% -400.0% -3694.0% 0.0% 0.0% 0.0% 0.0%
Koszty finansowe (mln) 0 0 1 0 -4 2 2
EBITDA (mln) -13 -19 -44 -83 -127 -169 -132
EBITDA(%) -641.3% -391.1% -3728.2% 0.0% 0.0% 0.0% 0.0%
Podatek (mln) 0 0 0 -0 0 0 0
Zysk Netto (mln) -14 -19 -46 -83 -123 -161 -135
Zysk netto Δ r/r 0.0% 40.1% 137.7% 82.5% 47.9% 30.2% -16.1%
Zysk netto (%) -664.3% -401.2% -3869.7% 0.0% 0.0% 0.0% 0.0%
EPS -0.63 -0.53 -1.15 -2.07 -3.03 -3.74 -2.58
EPS (rozwodnione) -0.63 -0.53 -1.15 -2.07 -3.03 -3.74 -2.58
Ilośc akcji (mln) 22 36 40 40 41 43 52
Ważona ilośc akcji (mln) 22 36 40 40 41 43 52
Waluta USD USD USD USD USD USD USD